Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1984-07-31
1986-06-03
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514561, A61K 3119, A61K 31195, A61K 3113
Patent
active
045930449
ABSTRACT:
The invention relates to the use of naproxen lysinate, ketoprofen lysinate and/or diclofenac lysinate in the form of an injectable solution in the treatment of inflammations and rheumatic disorders, and to injectable solutions containing the anti-inflammatory active compound naproxen, ketoprofen or diclofenac in the form of its lysinate.
REFERENCES:
patent: 2101867 (1937-12-01), Miller et al.
patent: 3832465 (1974-08-01), Ghadimi
patent: 3845210 (1974-10-01), Sato et al.
patent: 3876801 (1975-04-01), Tixier
patent: 4241086 (1980-12-01), Iwao et al.
patent: 4486436 (1984-12-01), Sunshine et al.
Griffin Ronald W.
Merckle GmbH
LandOfFree
Injectable solution for the treatment of inflammations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable solution for the treatment of inflammations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable solution for the treatment of inflammations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1233011